Advertisement
UK markets open in 5 hours 23 minutes
  • NIKKEI 225

    39,148.97
    +79.29 (+0.20%)
     
  • HANG SENG

    19,473.67
    -162.55 (-0.83%)
     
  • CRUDE OIL

    79.72
    -0.08 (-0.10%)
     
  • GOLD FUTURES

    2,434.30
    -4.20 (-0.17%)
     
  • DOW

    39,806.77
    -196.82 (-0.49%)
     
  • Bitcoin GBP

    55,868.54
    +3,812.90 (+7.32%)
     
  • CMC Crypto 200

    1,510.10
    +155.69 (+11.48%)
     
  • NASDAQ Composite

    16,794.88
    +108.91 (+0.65%)
     
  • UK FTSE All Share

    4,590.38
    +6.15 (+0.13%)
     

Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024

Autolus Therapeutics plc
Autolus Therapeutics plc

LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its first quarter 2024 financial results and operational highlights before open of US markets on Tuesday, May 14, 2024.

Management will host a conference call and webcast at 8:30 am EDT/1:30 pm BST to discuss the company’s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call.

A simultaneous audio webcast and replay will be accessible on the events section of Autolus’ website.

ADVERTISEMENT

Contact:

Olivia Manser
+44 (0) 7780 471568
o.manser@autolus.com

Julia Wilson
+44 (0) 7818 430877 
j.wilson@autolus.com

Susan A. Noonan
S.A. Noonan Communications
+1-917-513-5303 
susan@sanoonan.com